About Deoxyguanosine kinase, mitochondrial
Deoxyguanosine kinase, mitochondrial (DGUOK) is a protein
from Homo sapiens identified by UniProt accession
Q16854, 277 residues long.
MolForge cross-references it against 0 known binders and
134 disease associations.
Target properties
| Protein name | Deoxyguanosine kinase, mitochondrial |
| UniProt accession | Q16854 |
| Gene | DGUOK |
| Organism | Homo sapiens |
| Length | 277 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (134)
Diseases linked to this target (Open Targets).
- mitochondrial DNA depletion syndrome 3 (hepatocerebral type) · score 0.80
- progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 · score 0.77
- Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency · score 0.75
- portal hypertension · score 0.65
- mitochondrial DNA depletion syndrome · score 0.55
- genetic disorder · score 0.49
- mitochondrial disease · score 0.37
- Cholestasis · score 0.37
- neurodegenerative disease · score 0.37
- cholestasis · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16854-F1 | alphafold | PREDICTED | 86.08 | — |
Amino-acid sequence (277 residues)
MAAGRLFLSR LRAPFSSMAK SPLEGVSSSR GLHAGRGPRR LSIEGNIAVG KSTFVKLLTK TYPEWHVATE PVATWQNIQA AGTQKACTAQ SLGNLLDMMY REPARWSYTF QTFSFLSRLK VQLEPFPEKL LQARKPVQIF ERSVYSDRYI FAKNLFENGS LSDIEWHIYQ DWHSFLLWEF ASRITLHGFI YLQASPQVCL KRLYQRAREE EKGIELAYLE QLHGQHEAWL IHKTTKLHFE ALMNIPVLVL DVNDDFSEEV TKQEDLMREV NTFVKNL
Explore Deoxyguanosine kinase, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets